Eli Lilly’s oral obesity treatment efficacy falls short of expectations, says BMO’s Evan SeigermanAugust 7, 2025
Share Facebook Twitter LinkedIn Pinterest Email Jason Hunter, JPMorgan head of technical strategy, joins ‘Closing Bell’ to discuss the key support level for equity markets, what’s kept this market resilient and much more.